Filters: Author is I. Poggesi [Clear All Filters]
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice.; 2013. (Population Approach Group Europe (PAGE)).
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression. Athens, Greece; 2011. (Population Approach Group Europe (PAGE) 20th Meeting).
Bayesian population approaches to the analysis of dose escalation studies. Computer Methods and Programs in Biomedicine. 2011.
Bayesian population modelling of Phase I dose escalation studies: Gaussian process vs parametric approaches. IEEE Transactions on Biomedical Engineering. 2011.
Integrated model for clinical response and dropout in depression trials: a state-space approach. Berlin, Germany; 2010. (Population Approach Group in Europe (PAGE) 19th Meeting).
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches. Turin, Italy; 2010. (Congresso Nazionale di Bioingegneria 2010).
A state-space approach to disease and dropout modelling in phase II clinical trials. Turin, Italy; 2010. (Congresso Nazionale di Bioingegneria 2010).
Development and comparison of Bayesian population models for Phase I dose escalation. Houston, TX, USA; 2010. (Bayesian Biostatistics Conference 2010).
Disease and dropout modelling in depression trials: a state-space approach. Noordwijkerhout, The Netherlands; 2010. (6th International Symposium on Measurement and Kinetics of In Vivo Drug Effects).
A Data Mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials.; 2010. (Congresso Nazionale di Bioingegneria).
Dose escalation studies: a comparison among Bayesian models. St. Petersburg, Russia; 2009. (Population Approach Group Europe (PAGE) 18th Meeting).
Dose escalation studies: A comparison between NONMEM and a novel Bayesian tool. Marseille, France; 2008. (Population Approach Group Europe (PAGE) 17th Meeting).
A mininal model of tumor growth inhibition. IEEE Transaction on Biomedical Engineering. 2008;55:2683-90.
A mathematical model to study the effects of drugs administration on tumor growth dynamics. Mathematical Biosciences. 2006;2:127-51.
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administrations of anticancer agents. Cancer Research. 2004;64:1094-101.
In vitro cells growth pharmacodynamic studies: a new nonparametric approach to determine the relative importance of drug concentration and treatment time. Cancer Chemotherapy and Pharmacology. 2003;52:507-13.
Nonparametric AUC estimation in population studies with incomplete sampling: a Bayesian approach. Journal of Pharmacokinetics and Pharmacodynamics. 2002;29:445-71.